ALADDIN Study: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation
Status:
Completed
Trial end date:
2006-02-01
Target enrollment:
Participant gender:
Summary
ALADDIN is a research study to investigate the safety and effectiveness of leuprolide (a
hormone drug) to improve the cognitive function and slow the progression of Alzheimer's
disease (AD). In women leuprolide is commonly used to treat hormone related conditions such
as endometriosis and uterine fibroids. The study will include treatment of women 65 years and
older with mild to moderate Alzheimer's disease who reside in the community.